跳至主要内容
临床试验/NCT03528915
NCT03528915已完成不适用

Conjunctivitis Incidence in the Newborn Within the First Week of Life: Impact of the Prophylactic Use of Rifamycine(CRY NOT).

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 881 人开始时间: 2015年9月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
881
试验地点
1
主要终点
Occurrence of conjunctivitis during the first 8 days of life in newborns

研究概览

简要总结

The French guidelines for the use of Rifamycine eye drops in delivery room to prevent neonatal conjunctivitis have been actualized. Only newborns exposed to risk factors of conjunctivitis should be treated, compared to previous guidelines, treating all newborns. currently, there are no data describing risk factors for neonatal conjunctivitis. This study evaluated the incidence of conjunctivitis with or without Rifamycine eye drops treatment in the delivery room. Then risk factors for neonatal conjunctivitis where analyzed.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
36 Weeks 至 36 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Newborns at the University Hospital of Amiens> 36SA,
  • Admitted in maternity at the exit of nursery

排除标准

  • Newborns at the Amiens University Hospital <36SA
  • Eye drops for any medical reason within the first day of life.

结局指标

主要结局

Occurrence of conjunctivitis during the first 8 days of life in newborns

时间窗: 8 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Prevalence of Conjunctivitis and Indentification of... | 临床试验